Stay updated on Efficacy of Lisdexamfetamine in Young Adults With ADHD Clinical Trial
Sign up to get notified when there's something new on the Efficacy of Lisdexamfetamine in Young Adults With ADHD Clinical Trial page.

Latest updates to the Efficacy of Lisdexamfetamine in Young Adults With ADHD Clinical Trial page
- CheckyesterdayChange DetectedThe study record history shows an addition of Revision: v3.5.0 and a deletion of Revision: v3.4.3.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe record history shows a new revision v3.4.3 added and v3.4.2 removed.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check43 days agoChange DetectedAddition of Revision: v3.4.2 and removal of a site-wide funding notice (v3.4.1) are UI/system updates and do not affect study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check50 days agoChange DetectedThe page now includes a government funding notice. It also shows a new version entry, Revision: v3.4.1, with the previous Revision: v3.4.0 removed from the history.SummaryDifference0.8%

- Check58 days agoChange DetectedThe changes are minor UI and versioning updates: the page now shows a glossary toggle, color-coded additions and deletions, and a revision label updated from v3.3.4 to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1%

- Check93 days agoChange DetectedThe page history shows a new revision tag (v3.3.3) and removal of the HHS Vulnerability Disclosure footer link, which are minor history/UI updates that do not affect study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Efficacy of Lisdexamfetamine in Young Adults With ADHD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of Lisdexamfetamine in Young Adults With ADHD Clinical Trial page.